Skip to content

King Pharmaceuticals KG European Hospital Liability — Year 2

Other product segments

All other lines
32.4%
Commercial Auto Liability
17.6%
General Liability
10.4%
International
6.9%

Similar metrics at other companies

Greenlight Capital RE, Ltd. logo
GLREFinancial — Year 2
51.6%-15.6pp
American International Group logo
AIGUK/Europe Casualty and Financial lines — Year 2 (as a percent)
13.4%-0.2pp
Greenlight Capital RE, Ltd. logo
GLREHealth — Year 2
83%+0.2pp
CNA Financial logo
CNAMedical Professional Liability — Year 2
16.6%+0.3pp
Axis Capital Holders logo
AXSInsurance — Year 2
38.8%
American International Group logo
AIGUK/Europe and Japan Personal Insurance — Year 2 (as a percent)
25.9%+0.1pp

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's european hospital liability — year 2.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's european hospital liability — year 2?
King Pharmaceuticals (KG) reported european hospital liability — year 2 of 7.1% in Q4 2025.
What does european hospital liability — year 2 mean?
This metric tracks the financial performance or claim development for the second year of the underwriting cycle within the European Hospital Liability segment. It allows for the assessment of how loss estimates mature and change as more information becomes available after the initial policy year.